Add news
March 2010
April 2010
May 2010June 2010July 2010
August 2010
September 2010October 2010
November 2010
December 2010
January 2011
February 2011March 2011April 2011May 2011June 2011July 2011August 2011September 2011October 2011November 2011December 2011January 2012February 2012March 2012April 2012May 2012June 2012July 2012August 2012September 2012October 2012November 2012December 2012January 2013February 2013March 2013April 2013May 2013June 2013July 2013August 2013September 2013October 2013November 2013December 2013January 2014February 2014March 2014April 2014May 2014June 2014July 2014August 2014September 2014October 2014November 2014December 2014January 2015February 2015March 2015April 2015May 2015June 2015July 2015August 2015September 2015October 2015November 2015December 2015January 2016February 2016March 2016April 2016May 2016June 2016July 2016August 2016September 2016October 2016November 2016December 2016January 2017February 2017March 2017April 2017May 2017June 2017July 2017August 2017September 2017October 2017November 2017December 2017January 2018February 2018March 2018April 2018May 2018June 2018July 2018August 2018September 2018October 2018November 2018December 2018January 2019February 2019March 2019April 2019May 2019June 2019July 2019August 2019September 2019October 2019November 2019December 2019January 2020February 2020March 2020April 2020May 2020June 2020July 2020August 2020September 2020October 2020
News Every Day |

Take the jab or lose your job: Medical journal calls for a MANDATORY Covid vaccine, says ‘noncompliance should incur a penalty’

Take the jab or lose your job: Medical journal calls for a MANDATORY Covid vaccine, says ‘noncompliance should incur a penalty’

With half the US population reportedly unwilling to submit to an experimental Covid-19 shot, a new scientific paper has shed light on how state health authorities might enforce compliance with vaccine mandates.

Published in the New England Journal of Medicine on Thursday, the paper outlines strategies for circumventing widespread fears over the safety of a rushed-to-market vaccine against the novel coronavirus, providing health authorities with a playbook for coercing a skittish populace.

The writers acknowledge that voluntary measures should be tried first, rather than mandating the vaccine for everyone out of the gate. However, if the target population doesn't comply within a trial period, a mandate should be rolled out, and the penalties for refusing to submit should be harsh. Given “the costs of a failed voluntary scheme,” the writers warn, authorities should wait no more than a few weeks before rolling out a mandate if uptake falls short of expectations.

Also on rt.com
RT
Virginia health chief says he will MANDATE coronavirus vaccine, ‘strongly opposes’ exemptions

The paper says “six substantive criteria” must be met before a Covid-19 vaccine is imposed by the state. A federal body, the Advisory Committee on Immunization Practices, must greenlight administration to certain groups of the populace first, and “only recommended groups should be considered for a vaccination mandate.”

High-risk” groups should be given priority on that list.

[T]he elderly, health professionals working in high-risk situations or working with high-risk patients…persons with certain underlying medical conditions,” and people living in “high-density settings such as prisons and dormitories” – as well as active-duty military service members – should be ordered to get the jab as soon as health officials are confident they have a sufficient supply to cover these groups, the paper suggests.

Rather than attempting to pass laws requiring certain populations to get the vaccine, the paper recommends that “noncompliance should incur a penalty” – and a “relatively substantial” one. The non-compliant should be threatened with “employment suspension or stay-at-home orders,” though fines or criminal charges are discouraged, because they “disadvantage the poor” and risk getting the mandate itself challenged in court. Worse, they “may stoke distrust without improving uptake,” it adds.

Whatever they do, authorities should avoid flaunting their relationship with vaccine manufacturers, the paper recommends - a tall order, given that President Donald Trump’s “Operation Warp Speed” vaccine development initiative is helmed by Moncef Slaoui, the former head of pharma giant GlaxoSmithKline’s vaccine division who had to quit the board of directors of Moderna - a frontrunner in the vaccine race - to take the job. Slaoui notoriously was forced to offload over $10 million in Moderna stock after its value briefly skyrocketed following the announcement of promising early trial results.

For the non-high-risk groups, the writers suggest authorities “encourage voluntary uptake…using means such as public education campaigns and free vaccination.” Health officials have been hard at work conducting focus groups on which variety of “influencers” might best convince the American people to embrace what would be the quickest vaccine rollout in history (the standard timetable for vaccine development and approval, complete with post-shot monitoring for side effects, is 10 years or more) and what kind of emotional tone the message should take.

Also on rt.com
© Reuters / Dado Ruvic
Only 42% of Americans would take a Covid-19 vaccine before November, poll reveals, as Trump hints at jab by election day

A Yale University study conducted in July evaluated messaging strategies including guilt, economic benefit, trust in science, embarrassment, and community benefit to measure the effects on not only confidence in the vaccine itself but how willing the participants were to persuade others to take the shot – and how much they feared or looked down on those who had not received it. The results of that study have not been published.

The authors of the NEJM paper hail from Yale, Stanford University, and Indiana University, all institutions that have received funding from the Bill and Melinda Gates Foundation. The foundation has poured billions of dollars into developing multiple Covid-19 vaccines, setting up seven facilities to manufacture the leading candidates. While the US, UK, and several other countries have already paid for hundreds of millions of doses of multiple jabs, no western pharmaceutical company has yet declared victory in the vaccine race – on the contrary, the clinical trials of frontrunners like AstraZeneca and Moderna have yielded a bumper crop of troubling side effects.

Fears about the rushed rollout of the vaccine coupled with both Republicans and Democrats’ determination to turn the jab into a political football have convinced a majority of Americans that they don’t want to be among the first to get vaccinated. A poll conducted earlier this month suggested less than half the country would take the shot, even if they were paid $100, and polling shows the portion of Americans willing to take it has declined steadily since May.

Think your friends would be interested? Share this story!



Read also

PDP, APC in verbal war over N3bn COVID-19 fund, palliatives in Ekiti

Martin Lewis warns about quiet change to Universal Credit that will cut payments for ‘up to 450,000’ next month

Tupperware Brands extends its 2,500% rally after 3rd quarter earnings top estimates



News, articles, comments, with a minute-by-minute update, now on Today24.pro




Today24.pro — latest news 24/7. You can add your news instantly now — here